Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$66 Mln
Revenue (TTM)
$119 Mln
Net Profit (TTM)
$0 Mln
ROE
-1.1 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.5
Industry P/E
--
EV/EBITDA
-0.2
Div. Yield
0 %
Debt to Equity
0.8
Book Value
$8.5
EPS
$-5.4
Face value
--
Shares outstanding
18,311,626
CFO
$-623.12 Mln
EBITDA
$-665.52 Mln
Net Profit
$-706.47 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Outset Medical Inc (OM)
| 8.1 | 14.9 | 8.1 | -63.2 | -75.6 | -65.7 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Outset Medical Inc (OM)
| -77.7 | -79.2 | -79.0 | -44.0 | -18.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Outset Medical Inc (OM)
|
4.0 | 66.1 | 119.5 | -81.7 | -54.0 | -106.2 | -- | 0.5 |
| 7.9 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,510.1 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10 | 1.0 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 112.8 | 6,549.6 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.0 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,964.3 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.9 | 9.0 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,716.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.5 | 2.6 |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification,... on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Address: 3052 Orchard Drive, San Jose, CA, United States, 95134 Read more
President, CEO & Chairman
Ms. Leslie L. Trigg
President, CEO & Chairman
Ms. Leslie L. Trigg
Headquarters
San Jose, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Outset Medical Inc (OM) is $4.01 (NASDAQ) as of 02-Apr-2026 16:01 EDT. Outset Medical Inc (OM) has given a return of -75.6% in the last 3 years.
Since, TTM earnings of Outset Medical Inc (OM) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.68
|
0.44
|
|
2024
|
-0.03
|
0.12
|
|
2023
|
-0.09
|
0.13
|
|
2022
|
-0.48
|
0.31
|
|
2021
|
-1.05
|
0.37
|
The 52-week high and low of Outset Medical Inc (OM) are Rs 21.98 and Rs 3.00 as of 05-Apr-2026.
Outset Medical Inc (OM) has a market capitalisation of $ 66 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Outset Medical Inc (OM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.17
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.